Skip to content
Anthony Tennyson, Awakn Life Sciences episode artwork

Jul 9, 2021 24 min

Anthony Tennyson, Awakn Life Sciences

from Psychedelic Spotlight Podcast Hosted by David Flores, Awakn Life Sciences, Anthony Tennyson, Global Trac Solutions Inc., Psychedelic Spotlight

In this episode of the Psychedelic Spotlight podcast, we feature Anthony Tennyson, CEO of Awakn Life Sciences, a biotechnology company with clinical operations developing and delivering psychedelic medicine to treat addiction. In our conversation with Anthony, we gain insight on Awakn's psychedelic therapy delivery activities, the company's plans to expand across the EU, and what the addition of renowned neuroscientist, Professor David Nutt as their Chief Research Officer means to their ongoing growth initiatives. *To learn more about the company featured in this episode and the work they’re doing, visit their website: AwaknLifeSciences.com *Get the latest industry news around all things psychedelics by visiting our website and be sure to subscribe to our newsletter to never miss a thing. Visit our Website: PsychedelicSpotlight.com Subscribe to our YouTube Channel Follow us on Instagram Like us on Facebook Follow us on Twitter *This episode was recorded on June 30, 2021.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Anthony Tennyson, Awakn Life Sciences

0:00 24:24

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Psychedelic Spotlight Podcast?

This episode is 24 minutes long.

When was this Psychedelic Spotlight Podcast episode published?

This episode was published on July 9, 2021.

Can I download this Psychedelic Spotlight Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.